Valuation Insights - Third Quarter 2020

Global economic conditions and U.S. government intervention in the form of two recently signed executive orders has promoted domestic development and manufacturing of essential medicines, which may significantly alter the case for reshoring in the pharmaceutical industry.

In our Technical Notes section, we outline the key accounting, financial and economic analyses that parties and counsel to M&A transactions should undertake during this period of economic disruption.

In our International in Focus article, we showcase the Duff & Phelps 2020 Global Enforcement Review, our latest report on global anti-money laundering (AML) enforcement that provides a brief history of money laundering fines, key AML findings and where regulations are hitting hardest across all regions globally.

In our Spotlight article, we take a closer look at the Dow Jones Industrial Average Special Report, a timely study that analyzed 30 large cap companies on U.S. stock exchanges to reveal the breadth of the stock market recovery and the impact COVID-19 has had on companies’ revenues, profit margins, earnings and dividends.

Finally, we summarize the SEC’s recently proposed rule to improve fund valuation practices for all registered investment companies at a time when experienced, independent and informed judgement when estimating fair value is required now more than ever.

In every issue of Valuation Insights, you will find industry market multiples that are useful for benchmark valuation purposes.

Be sure to check out our library of CPE-eligible webcasts, where our valuation experts discuss issues and topics that may be impacting your business.  

We hope that you will find this and future issues of the newsletter informative.